Citizen data revealed genetic variability in the SYNGAP1 gene, normal growth patterns, developmental delays and language reversion, gait and muscle issues, hospitalization burden in SRD patients, and seizure types in the largest natural history sample to date. Here, SYNGAP1 is linked to dopa-responsive dystonia due to sepiapterin reductase deficiency.